The goal of this project is to use rat models of emotional reactivity and social stress to test the function of novel candidate genes that arise from microarray studies in human postmortem brains of subjects who suffered from severe mood disorders (major depression and bipolar illness). In this proposal, we develop a specific hypothesis and describe the strategy that will be used to implicate a family of novel candidates in mood and affect. The human microarray studies (described in the Overview and in Project 1) pointed to the family of fibroblast growth factors (FGF's) and their receptors as being altered in frontal cortical regions of severely depressed patients relative to control subjects. This change in gene expression was not seen in the brain of bipolar subjects. The FGF family has been implicated in the control of development and differentiation of the brain and in neurogenesis. However, there was little evidence implicating this family in the control of emotional reactivity, stress responsiveness or mood disorders. The array findings have led us to the specific hypothesis that the FGF family is involved either in the etiology or the expression of severe depression. In order to test this hypothesis, we plan to use rats that have been screened for differential responsiveness to stress and anxiety-like situations (High Responders and Low Responders). This allows us to investigate the connection between individual differences in emotionality and anxiety-lake behavior and this gene family. In addition, these animals will either be handled (controls) or subjected to social defeat conditions (stress), which we have shown to activate the same neural pathways engaged by depression in humans. Using this animal model, we plan to address the following questions: 1) Do high responders and low responders differ in the expression of FGF-related genes, either basally or following social defeat? 2) Do various classes of antidepressants have any effects on the expression of the FGF genes, either in control or in socially defeated animals? 3) If we administer members of the FGF family to newborn rats, can we implicate them in hippocampal morphology and alterations in neurogenesis, and can we link these potential alterations to change in emotionality or stress reactivity? Together, these studies serve as a prototype for testing the potential function of genes that were not previously implicated in the severe mood disorders but whose expression is significantly altered in the brain of depressed or bipolar individuals. This will allow us to extend our understanding of the fundamental molecular and neuralmechanisms associated with mood disorders and to develop novel targets for treatment and prevention of these devastating illnesses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH060398-09
Application #
7483208
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2007-09-01
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
9
Fiscal Year
2007
Total Cost
$342,044
Indirect Cost
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Turner, Cortney A; Sharma, Vikram; Hagenauer, Megan H et al. (2018) Connective Tissue Growth Factor Is a Novel Prodepressant. Biol Psychiatry 84:555-562
Morgan, Ling Z; Rollins, Brandi; Sequeira, Adolfo et al. (2016) Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders. Microarrays (Basel) 5:
Bunney, B G; Li, J Z; Walsh, D M et al. (2015) Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry 20:48-55
Li, Jun Z; Bunney, Blynn G; Meng, Fan et al. (2013) Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A 110:9950-5
Tomita, Hiroaki; Ziegler, Mary E; Kim, Helen B et al. (2013) G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 4:297
Wei, Qiang; Fentress, Hugh M; Hoversten, Mary T et al. (2012) Early-life forebrain glucocorticoid receptor overexpression increases anxiety behavior and cocaine sensitization. Biol Psychiatry 71:224-31
Garcia-Fuster, M Julia; Flagel, Shelly B; Mahmood, S Taha et al. (2012) Cocaine withdrawal causes delayed dysregulation of stress genes in the hippocampus. PLoS One 7:e42092
Turner, Cortney A; Watson, Stanley J; Akil, Huda (2012) The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76:160-74
Turner, Cortney A; Watson, Stanley J; Akil, Huda (2012) Fibroblast growth factor-2: an endogenous antidepressant and anxiolytic molecule? Biol Psychiatry 72:254-5
Sequeira, Adolfo; Martin, Maureen V; Rollins, Brandi et al. (2012) Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet 3:103

Showing the most recent 10 out of 48 publications